| Metric | Q4 2025 | Q3 2025 | Q4 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $145M | — | — | — | — |
| Op. Income | $42M | — | — | — | — |
| Gross Margin | 68.5% | — | — | — | — |
| Net Margin | 23.4% | — | — | — | — |
| EPS (Diluted) | $0.89 | — | — | — | — |
| Free Cash Flow | $36M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $145M |
| Cost of Revenue | $46M |
| GROSS PROFIT | $100M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $40M |
| SG&A Expenses | $40M |
| Other Expenses | $17M |
| Operating Expenses | $57M |
| Cost & Expenses | $103M |
| OPERATING INCOME | $42M |
| Interest Income | $132M |
| Interest Expense | $40M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $42M |
| Income Tax Expense | $8M |
| Net Income from Continuing Ops | $34M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $34M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $34M |
| D&A | $0 |
| EBIT | $42M |
| EBITDA | $42M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $145M |
| Cost of Revenue | $46M |
| GROSS PROFIT | $100M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $40M |
| SG&A Expenses | $40M |
| Other Expenses | $17M |
| Operating Expenses | $57M |
| Cost & Expenses | $103M |
| OPERATING INCOME | $42M |
| Interest Income | $132M |
| Interest Expense | $40M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $42M |
| Income Tax Expense | $8M |
| Net Income from Continuing Ops | $34M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $34M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $34M |
| D&A | $0 |
| EBIT | $42M |
| EBITDA | $42M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $34M |
| Depreciation & Amortization | $0 |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | $3M |
| Change in Working Capital | $0 |
| OPERATING CASH FLOW | $37M |
| Capital Expenditure | -$1M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | -$86M |
| NET CASH FROM INVESTING | -$87M |
| Net Debt Issuance | $30M |
| Common Stock Repurchased | -$36M |
| Common Dividends Paid | -$14M |
| Other Financing Activities | $37M |
| NET CASH FROM FINANCING | $17M |
| FREE CASH FLOW | $36M |
| Net Change in Cash | -$33M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $163M |
| Short-Term Investments | $988M |
| Net Receivables | $2.0K |
| Inventory | $0 |
| Other Current Assets | -$2.0K |
| TOTAL CURRENT ASSETS | $1.2B |
| PP&E (Net) | $0 |
| Goodwill | $373M |
| Intangible Assets | $2M |
| Long-Term Investments | $8.0B |
| Tax Assets | $0 |
| Other Non-Current Assets | -$7.9B |
| TOTAL NON-CURRENT ASSETS | $420M |
| TOTAL ASSETS | $9.9B |
| Account Payables | $0 |
| Short-Term Debt | $220M |
| Deferred Revenue | $0 |
| Other Current Liabilities | -$55M |
| TOTAL CURRENT LIABILITIES | $165M |
| Long-Term Debt | $50M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $18M |
| Other Non-Current Liabilities | $8.1B |
| TOTAL NON-CURRENT LIABILITIES | $8.2B |
| TOTAL LIABILITIES | $8.4B |
| Common Stock | $104M |
| Additional Paid-In Capital | $413M |
| Retained Earnings | $1.1B |
| Treasury Stock | -$131M |
| Accum. Other Comp. Income | -$42M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $1.5B |
| Minority Interest | $0 |
| TOTAL EQUITY | $1.5B |
| TOTAL LIABILITIES & EQUITY | $9.9B |
| Total Debt | $311M |
| Net Debt | $148M |
